Brooks Laboratories Limited — Important, 25-02-2025: Updates

Brooks Laboratories Limited's Board has approved the un-audited financial results for the quarter and nine months ended December 31, 2024. The company reported a revenue from operations of ₹20.52 crore and total income of ₹20.54 crore for the quarter, showcasing a slight decline compared to the previous quarter's ₹20.79 crore. Notably, net profit after tax stood at ₹9.37 crore, a marginal decrease from ₹9.56 crore in the prior quarter. Cost of materials consumed and other expenses saw fluctuations, impacting the profitability margins.

In a strategic move, the company is focusing on enhancing investments in its joint venture, Brooks Steriscience Limited, having already utilized ₹43.22 crore from its recent preferential share offerings. This approach could potentially lead to greater operational leverage and improved financial health moving forward. Overall, investors should maintain a watchful eye on these developments, as they could signal both risks and opportunities for growth in the coming quarters.